Quest for the right Drug

|
עמוד הבית / קוד-אקמול 15/325 / מידע מעלון לרופא

קוד-אקמול 15/325 COD-ACAMOL 15/325 (CODEINE PHOSPHATE, PARACETAMOL)

תרופה במרשם תרופה בסל נרקוטיקה ציטוטוקסיקה

צורת מתן:

פומי : PER OS

צורת מינון:

טבליה : TABLETS

Pharmacological properties : תכונות פרמקולוגיות

Pharmacodynamic Properties

5.1. Pharmacodynamic properties
Pharmacotherapeutic group: Opioids in combination with non-opioid analgesics, ATC code: N02AJ06
Paracetamol (N02B E51) has analgesic and antipyretic actions. It is a weak inhibitor of prostaglandin biosynthesis. Single or repeated therapeutic doses of paracetamol do not affect the cardiovascular or respiratory systems. Gastric irritation, erosion, or bleeding is not produced by paracetamol. There is minimal effect on platelets, no effect on bleeding time or excretion of uric acid.
Codeine (N02A A59) is a centrally acting weak analgesic. Codeine exerts its effect through μ opioid receptors, although codeine has low affinity for these receptors, and its analgesic effect is due to its 
Cod Acamol 15/325 tablets MW Feb 2024
conversion to morphine. Codeine, particularly in combination with other analgesics such as paracetamol, has been shown to be effective in acute nociceptive pain.
Codeine affects the CNS and the gut, including analgesia, drowsiness, mood changes, respiratory depression, reduced gastrointestinal motility, nausea or vomiting, changes in the endocrine and autonomic nervous system. Codeine's effect on pain relief is selective, and it does not affect other sensations such as touch, vibration, vision, or hearing.

Pharmacokinetic Properties

5.2. Pharmacokinetic properties

Paracetamol is readily absorbed from the gastrointestinal tract with peak plasma concentrations occurring about 30 minutes to 2 hours after ingestion. Paracetamol is metabolized in the liver and excreted in the urine mainly as the glucuronide and sulphate conjugates, with about 10% as glutathione conjugates. Less than 5% is excreted as unchanged paracetamol. The elimination half- life varies from about 1-4 hours. Plasma protein binding is negligible at usual therapeutic concentrations, although this is dose dependent. A minor hydrolated metabolite which is usually produced in very small amounts by mixed function oxidases in the liver and which is usually detoxified by conjugation with liver glutathione may accumulate following paracetamol overdosage and cause liver damage.
Codeine and its salts are absorbed from the gastro-intestinal tract and peak plasma concentrations are produced in about 1 hour. It is metabolized in the liver to morphine and norcodeines. Codeine and its metabolites are excreted almost entirely by the kidney, mainly as conjugates with glucuronic acid. The plasma half-life is between 3 and 4 hours.

שימוש לפי פנקס קופ''ח כללית 1994 Mild to moderate pain
תאריך הכללה מקורי בסל 01/01/1995
הגבלות תרופה שאושרה לשימוש כללי בקופ'ח

בעל רישום

TEVA ISRAEL LTD

רישום

040 04 22978 01

מחיר

0 ₪

מידע נוסף

עלון מידע לרופא

10.05.22 - עלון לרופא 19.08.23 - עלון לרופא 02.03.24 - עלון לרופא 30.04.24 - עלון לרופא

עלון מידע לצרכן

29.05.22 - עלון לצרכן אנגלית 29.05.22 - עלון לצרכן עברית 29.05.22 - עלון לצרכן ערבית 02.03.24 - עלון לצרכן עברית 19.04.24 - עלון לצרכן עברית 12.05.22 - החמרה לעלון 05.03.19 - החמרה לעלון 14.07.19 - החמרה לעלון 02.03.24 - החמרה לעלון 19.04.24 - החמרה לעלון

לתרופה במאגר משרד הבריאות

קוד-אקמול 15/325

קישורים נוספים

RxList WebMD Drugs.com